Dow and DuPont reaffirm to close merger in August 2017
June 28 Dow Chemical Co and DuPont on Wednesday reaffirmed their expectation to close their merger in August.
April 25 Ovid Therapeutics Inc
* Ovid Therapeutics Inc sees IPO of 5.0 million shares of common stock - SEC filing
* Ovid Therapeutics Inc currently expect the initial public offering price to be between $15.00 and $17.00 per share of common stock
* Ovid Therapeutics says intends to use about $35 million of IPO proceeds to conduct and complete Phase 2 stars trial of OV101 in adults with angelman syndrome
* Ovid Therapeutics says intends to use about $17 million of IPO proceeds to conduct and complete Phase 1B/2A trial of OV935
* Ovid Therapeutics says intends to use about $7 million of IPO proceeds for other ongoing research and development activities related to additional drug candidates Source text: (bit.ly/2q04Gbz)
NEW YORK, June 28 The now-delayed U.S. Senate healthcare overhaul bill would boost state spending on Medicaid by $565 million in 2022, according to an independent report issued on Wednesday, while credit agencies said it would cause states to face downward pressure on their credit ratings.